ZA200501008B - A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods for preparing same - Google Patents

A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods for preparing same

Info

Publication number
ZA200501008B
ZA200501008B ZA200501008A ZA200501008A ZA200501008B ZA 200501008 B ZA200501008 B ZA 200501008B ZA 200501008 A ZA200501008 A ZA 200501008A ZA 200501008 A ZA200501008 A ZA 200501008A ZA 200501008 B ZA200501008 B ZA 200501008B
Authority
ZA
South Africa
Prior art keywords
new
epothilone derivatives
preparation
methods
well
Prior art date
Application number
ZA200501008A
Other languages
English (en)
Inventor
Koch Guido
Loiseleur Olivier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200501008(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200501008B publication Critical patent/ZA200501008B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200501008A 2002-09-13 2005-02-03 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods for preparing same ZA200501008B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221312.2A GB0221312D0 (en) 2002-09-13 2002-09-13 Organic compounds

Publications (1)

Publication Number Publication Date
ZA200501008B true ZA200501008B (en) 2006-12-27

Family

ID=9944042

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501008A ZA200501008B (en) 2002-09-13 2005-02-03 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods for preparing same

Country Status (30)

Country Link
US (1) US7470792B2 (ja)
EP (1) EP1539768B1 (ja)
JP (1) JP4628102B2 (ja)
KR (1) KR20050042500A (ja)
CN (1) CN100522968C (ja)
AR (1) AR041231A1 (ja)
AT (1) ATE373663T1 (ja)
AU (2) AU2003267349B2 (ja)
BR (1) BR0314263A (ja)
CA (1) CA2497119C (ja)
CY (1) CY1107794T1 (ja)
DE (1) DE60316456T2 (ja)
DK (1) DK1539768T3 (ja)
EC (1) ECSP055652A (ja)
ES (1) ES2290489T3 (ja)
GB (1) GB0221312D0 (ja)
HK (1) HK1078853A1 (ja)
IL (1) IL166829A (ja)
MX (1) MXPA05002785A (ja)
MY (1) MY140442A (ja)
NO (1) NO20051794L (ja)
NZ (1) NZ538612A (ja)
PE (1) PE20050052A1 (ja)
PL (1) PL375039A1 (ja)
PT (1) PT1539768E (ja)
RU (2) RU2404985C2 (ja)
SG (1) SG155770A1 (ja)
TW (1) TWI289563B (ja)
WO (1) WO2004024735A2 (ja)
ZA (1) ZA200501008B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO2004018478A2 (en) 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
CA2799202C (en) 2010-05-18 2016-07-05 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6498257B1 (en) 1998-04-21 2002-12-24 Bristol-Myers Squibb Company 2,3-olefinic epothilone derivatives
GB9810659D0 (en) * 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
EP1226142A2 (en) * 1999-07-22 2002-07-31 Schering Aktiengesellschaft Process for the production of epothiolone b and derivatives as well as intermediate products for this process
US6593115B2 (en) * 2000-03-24 2003-07-15 Bristol-Myers Squibb Co. Preparation of epothilone intermediates
IL155306A0 (en) 2000-10-13 2003-11-23 Univ Mississippi Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby
NZ537870A (en) * 2002-07-31 2007-03-30 Schering Ag New effector conjugates, process for their production and their pharmaceutical use

Also Published As

Publication number Publication date
BR0314263A (pt) 2005-07-05
HK1078853A1 (en) 2006-03-24
JP2006511469A (ja) 2006-04-06
AR041231A1 (es) 2005-05-11
JP4628102B2 (ja) 2011-02-09
RU2404985C2 (ru) 2010-11-27
ECSP055652A (es) 2005-05-30
AU2003267349B2 (en) 2008-05-01
PL375039A1 (en) 2005-11-14
CA2497119A1 (en) 2004-03-25
PT1539768E (pt) 2007-12-17
DE60316456T2 (de) 2008-06-19
PE20050052A1 (es) 2005-03-28
CA2497119C (en) 2011-08-02
TWI289563B (en) 2007-11-11
WO2004024735A2 (en) 2004-03-25
NO20051794D0 (no) 2005-04-12
ES2290489T3 (es) 2008-02-16
KR20050042500A (ko) 2005-05-09
SG155770A1 (en) 2009-10-29
AU2008203451A1 (en) 2008-08-21
WO2004024735A3 (en) 2004-07-22
EP1539768B1 (en) 2007-09-19
NZ538612A (en) 2008-01-31
CY1107794T1 (el) 2013-06-19
CN1681824A (zh) 2005-10-12
RU2343155C2 (ru) 2009-01-10
DK1539768T3 (da) 2008-01-07
TW200413388A (en) 2004-08-01
CN100522968C (zh) 2009-08-05
DE60316456D1 (de) 2007-10-31
EP1539768A2 (en) 2005-06-15
ATE373663T1 (de) 2007-10-15
US7470792B2 (en) 2008-12-30
US20060106073A1 (en) 2006-05-18
RU2008129613A (ru) 2010-01-27
MY140442A (en) 2009-12-31
NO20051794L (no) 2005-04-12
IL166829A (en) 2011-01-31
MXPA05002785A (es) 2005-06-03
AU2003267349A1 (en) 2004-04-30
RU2005110925A (ru) 2006-01-20
GB0221312D0 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
IL215617A0 (en) Substituted pyrrolo-pyrazole derivatives and process for their preparation
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
IL176472A (en) Process for the preparation of pyridine derivatives
AU3804800A (en) Novel epothilone derivatives, method for producing them and their pharmaceuticaluse
HK1075650A1 (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
HK1108580A1 (en) A process for the preparation of [1,4,5]-oxadiazepine derivatives
PL371319A1 (en) Coumarin derivatives, process for their production and use thereof
PL377741A1 (pl) Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego
GB2394164B (en) Process for the preparation of a coffee product
TWI318211B (en) Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
ZA200501008B (en) A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods for preparing same
EP1501811A4 (en) PROCESS FOR THE PREPARATION OF THIAZOLE DERIVATIVE AND INTERMEDIATE COMPOUNDS THEREFOR
AU2003263622A1 (en) Process for preparing prostaglandin derivatives and starting materials for the same
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
AU2003288628A1 (en) A process for preparing tomato powder and products thereof
AU6233600A (en) Process for the production of epothiolone b and derivatives as well as intermediate products for this process
AU2003264894A8 (en) Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses
AU2002336085A1 (en) C2-substituted Indane-1-ones and their derivatives, method for their production and their use as medicaments
AU2002336983A1 (en) C2-disubstituted Indane-1-ones and their derivatives, method for their production and their use as medicaments